Yongjun Chen

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsCarbon capture engineering (excl. sequestration)Predictive and prognostic markersHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2025
KDM4A-driven SMAD5/TGFβ axis activation as a therapeutic target in cholangiocarcinoma: mechanistic insights and translational implications.

Qi Wang, Yiyang Kuai, Fei Xiong

|Oct 30, 2024
PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.

Wenzheng Liu, Yiyang Kuai, Da Wang

|Dec 05, 2023
Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.

Guanhua Wu, Qi Wang, Da Wang

|Sep 27, 2022
HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway.

Fei Xiong, Wenzheng Liu, Xin Wang

|Aug 12, 2022
Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma.

Fei Xiong, Tong Guo, Xin Wang

Pageof 1

Frequent Collaborators

1 joint publications

Fei Xiong

1 joint publications

Tong Guo

1 joint publications

Xin Wang

1 joint publications

Guanhua Wu